News Features Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s? Michael O'Riordan January 17, 2025
News Daily News Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD Todd Neale December 06, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News Closing the Left Atrial Septal Pouch For Stroke Prevention Explored in Small Trial Todd Neale November 25, 2024
News Conference News AHA 2024 ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS Michael O'Riordan November 21, 2024
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News AHA 2024 Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots Caitlin E. Cox November 17, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Conference News AHA 2024 US Obesity Epidemic Continues to Skyrocket, With No End in Sight Michael O'Riordan November 15, 2024
News Daily News High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low Michael O'Riordan November 13, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
Presentation TCT 2024 TCT 765: Lipid-Lowering Therapy in Contemporary PCI Practice Presenter: Patrick Serruys October 30, 2024
Presentation TCT 2024 TCT 766: Long-Acting Nitrates Before and After Revascularization of Chronic Coronary Syndrome: A Case Crossover Study From SCAAR Presenter: Sacharias von Koch October 30, 2024
Presentation TCT 2024 TCT 763: Trajectories of Adherence to Secondary Prevention Pharmacotherapy After Coronary Catheterization: A Retrospective Population-Based Study Presenter: Leon Heitmann October 30, 2024
Presentation TCT 2024 TCT 767: The Clinical Impact of Nicorandil Treatment on the Top of Standard Anti-Anginal Medications in Patients With Significant Coronary Artery Spasm up to 5 Years Presenter: Woo Jin Ahn October 30, 2024
Presentation TCT 2024 TCT 764: Clinical Outcomes of High Intensity Lipid Lowering Therapy in Patient Following Complex PCI Presenter: Young-Kwan Kim October 30, 2024
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
Presentation TCT 2024 The Case for Quality in Post PCI / Secondary Prevention Patients – Moving Knowledge to Action Presenter: Jennifer Rymer October 28, 2024